Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Anheuser-Busch InBev NV (ADR) (BUD)’s Big Revenue Beat

Anheuser-Busch InBev NV (ADR) (NYSE:BUD)With the sweltering heat of summer, a time when many people enjoy drinking a frosty brew, it seems appropriate to have a look at beer brewer stocks. Typically a defensive industry, these companies have generally been doing a good job growing volume lately. The world’s number one beer brewer, Anheuser-Busch InBev NV (ADR) (NYSE:BUD), reported revenue at the end of July that came in well ahead of the analyst consensus. Trading at a fair valuation, the stock may have more upside this year.

BUD at a Glance

Clearly, the Belgians know a thing or two about beer. With a huge $157.77 billion market cap, and around 118,000 employees, Anheuser-Busch InBev NV (ADR) (NYSE:BUD) is the world’s largest beer conglomerate. The Belgium-based company’s brands include venerable brews such as Stella Artois, Budweiser, Beck’s, Leffe, Michelob, Brahma and Jupiler. The stock is up around 24% in the last year, and yields around 2.10% at a fairly low payout ratio of 29%.

Strong Revenue Growth

The company has seen very steady earnings growth over the last few years, going from an annual EPS of $2.48 in 2009 to $4.55 in 2012 for an 83% increase. Despite a few misses along the way, the company looks well positioned for growth, with analysts expecting $4.83 per share over fiscal 2013 and a 3-5 year growth rate of around 24%.

The company’s most recent earnings report was upbeat. While Q2 2013 EPS of $0.93 missed expectations of $1.03, and were down from $1.21 in the same period a year ago, revenue beat quite substantially. Revenue for the quarter came in at $10.59 billion, up 7.26% year-over-year and well above the $10.2 billion consensus. The news sent the stock up 6%.

Geographically, Asia Pacific was the best performing region with a 5.1% volume increase for the quarter driven mainly by strength in China. The worst performing region was Western Europe, still mired in macro-economic difficulties, with a steep 7.2% volume decrease. Moving on to Latin America, the company’s incorporation of Grupo Modelo is going well according to management, and is expected to deliver around $1 billion in cost synergies over the next four years despite a fairly soft economy in the region.

Brazil, an important growth market, showed a small decline in volume, and things are expected to remain soft in the region throughout the year. Regarding the outlook more generally, the company expects strong growth in China to continue through 2013. Overall volume is expected to grow throughout the year, as well as revenue per hectoliter.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.